Anthropic Acquires Mithril Medicine as Professor Oak Reveals Founder Identity
Summary
Anthropic has acquired Mithril Medicine, a one-person biotech founded by Cody Tranbarger, who disclosed his identity as the X account Professor Oak. Tranbarger says he will continue Mithril's bispecific antibody programs for LAMA2-CMD and start several more at Anthropic, betting that AI orchestration lets one drug hunter run multiple programs at once.
Key Points
- Tranbarger says Mithril began as a virtual, decentralized, ultra-lean company backed by a small Atlas Venture seed.
- Tranbarger says the Pipeline-in-a-Person concept, shared in April, shaped the vision behind Anthropic's acquisition of Mithril.
- Tranbarger says orchestration and parallelization, not timeline compression, are AI's low-hanging fruit in drug development.